Cargando…
Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922
The present study examined the radiosensitization induced by a heat shock protein 90 inhibitor, N-vinylpyrrolidone (NVP)-AUY922, in CD133-positive cells in a hypoxic area of T98G spheroids. CD133-positive cells that are induced in the hypoxic microenvironment of spheroids have previously been report...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822487/ https://www.ncbi.nlm.nih.gov/pubmed/35154433 http://dx.doi.org/10.3892/ol.2022.13222 |
_version_ | 1784646617554485248 |
---|---|
author | Tani, Toshiaki Tojo, Naomi Ohnishi, Ken |
author_facet | Tani, Toshiaki Tojo, Naomi Ohnishi, Ken |
author_sort | Tani, Toshiaki |
collection | PubMed |
description | The present study examined the radiosensitization induced by a heat shock protein 90 inhibitor, N-vinylpyrrolidone (NVP)-AUY922, in CD133-positive cells in a hypoxic area of T98G spheroids. CD133-positive cells that are induced in the hypoxic microenvironment of spheroids have previously been reported to exhibit cancer stem cell-like properties. The present study used CD133-positive cells from a glioblastoma cell line (T98G) as cancer stem cell-like cells. CD133-positive and negative cells were sorted from T98G spheroids using fluorescence-activated cell sorting and used for colony formation assay. Colony formation assay results indicated that NVP-AUY922 enhanced radiosensitivity more strongly in CD133-positive cells compared with CD133-negative cells. This result showed that NVP-AUY922 was a preferential radiosensitization candidate targeting glioblastoma cancer stem cells. The mechanisms underlying radiosensitization by NVP-AUY922 are discussed in relation to the properties of cancer stem cells. Overall, HIF-1α inhibition by NVP-AUY922 may induce higher sensitization of cancer stem cells to radiation. |
format | Online Article Text |
id | pubmed-8822487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-88224872022-02-10 Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922 Tani, Toshiaki Tojo, Naomi Ohnishi, Ken Oncol Lett Articles The present study examined the radiosensitization induced by a heat shock protein 90 inhibitor, N-vinylpyrrolidone (NVP)-AUY922, in CD133-positive cells in a hypoxic area of T98G spheroids. CD133-positive cells that are induced in the hypoxic microenvironment of spheroids have previously been reported to exhibit cancer stem cell-like properties. The present study used CD133-positive cells from a glioblastoma cell line (T98G) as cancer stem cell-like cells. CD133-positive and negative cells were sorted from T98G spheroids using fluorescence-activated cell sorting and used for colony formation assay. Colony formation assay results indicated that NVP-AUY922 enhanced radiosensitivity more strongly in CD133-positive cells compared with CD133-negative cells. This result showed that NVP-AUY922 was a preferential radiosensitization candidate targeting glioblastoma cancer stem cells. The mechanisms underlying radiosensitization by NVP-AUY922 are discussed in relation to the properties of cancer stem cells. Overall, HIF-1α inhibition by NVP-AUY922 may induce higher sensitization of cancer stem cells to radiation. D.A. Spandidos 2022-03 2022-01-31 /pmc/articles/PMC8822487/ /pubmed/35154433 http://dx.doi.org/10.3892/ol.2022.13222 Text en Copyright: © Tani et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Tani, Toshiaki Tojo, Naomi Ohnishi, Ken Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922 |
title | Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922 |
title_full | Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922 |
title_fullStr | Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922 |
title_full_unstemmed | Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922 |
title_short | Preferential radiosensitization to glioblastoma cancer stem cell-like cells by a Hsp90 inhibitor, N-vinylpyrrolidone-AUY922 |
title_sort | preferential radiosensitization to glioblastoma cancer stem cell-like cells by a hsp90 inhibitor, n-vinylpyrrolidone-auy922 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822487/ https://www.ncbi.nlm.nih.gov/pubmed/35154433 http://dx.doi.org/10.3892/ol.2022.13222 |
work_keys_str_mv | AT tanitoshiaki preferentialradiosensitizationtoglioblastomacancerstemcelllikecellsbyahsp90inhibitornvinylpyrrolidoneauy922 AT tojonaomi preferentialradiosensitizationtoglioblastomacancerstemcelllikecellsbyahsp90inhibitornvinylpyrrolidoneauy922 AT ohnishiken preferentialradiosensitizationtoglioblastomacancerstemcelllikecellsbyahsp90inhibitornvinylpyrrolidoneauy922 |